Progress in study on the treatment of gastric cancer with docetaxel
10.11817/j.issn.1672-7347.2018.02.019
- VernacularTitle:多西他赛在胃癌治疗中的研究进展
- Author:
Gengyuan ZHANG
1
;
Hengrui DU
;
Zhenjiang WANG
;
Yanxian REN
;
Keshen WANG
;
Zuoyi JIAO
Author Information
1. 兰州大学第二医院普外一科
- Keywords:
gastric cancer;
docetaxel;
chemotherapy
- From:
Journal of Central South University(Medical Sciences)
2018;43(2):216-221
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer is one of the most common malignant gastrointestinal tumors.Docetaxel alone or combination with other drugs can attenuate the progress of disease,prolong the overall response rate and the median overall survival rate in advanced gastric cancer.However,the incidence of toxicities is high.Moreover,there is no uniform standard for dosage and course for docetaxel treatment.Currently,its efficacy is not definite.
